Followers | 373 |
Posts | 16790 |
Boards Moderated | 3 |
Alias Born | 03/07/2014 |
Friday, February 26, 2021 10:15:29 AM
Already tagged .0475 this AM
To be expected I guess - they gotta pay a hell of a lot of legal bills and "other" expenses still and gotta find actual CASH some place:
That is despite the reality that they appear to no longer own or operate any stem cell "clinics" and are based out of a rent-a-desk (virtual office literally at $268 per month or whatever) after CEO Tomas seemingly "gave away" the cell banking business and their former actual "facilities" for free to Sean Berman, just prior to going dark on SEC filing.
Gonna be fascinating to me to see what is their actual "business" they're still in, even on a appellate court remand back down to the lower court and likely another approx 1 yr of legal battles there????
They're in default on several large loans and at least two major creditors are suing them in court as we speak to "try" and recover anything they can = a bigger worry IMO almost than their FDA court "problems" and massive legal bills for same.
A court/judge ordered settlement agreement of the size debts they've defaulted on (two exceeding $million dollar range) can send them to BK as they're literally cash broke at any given time per all their last SEC filings before going "dark" and now with essentially no known real revenues??
This one is still on the "very interesting list" for sure just due to the FDA court case - but it's a dicey proposition too IMO as in real dicey due to sooo many legal battles and high expenses and now virtually cash broke and no real income any longer = a dangerous potential combo when creditors are on their ass now and chasing um with formal lawsuits.
11th circuit is it for now - it's a waiting game and it could be a month easily IMO as the appellate courts move slower than 3 legged turtles named Lucky :)
Posts contain only my amateur opinions, personal views and thoughts. I discuss stocks as a hobby only. Always do one's own due diligence before investing.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM